Last update 25 Jul 2024

Aviptadil

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
aviptadil acetate, Porcine vasoactive intestinal octacosapeptide, Vasoactive intestinal octacosapeptide (pig)
+ [13]
Mechanism
VIPR1 agonists(Vasoactive intestinal polypeptide receptor 1 agonists), VIPR2 agonists(Vasoactive intestinal polypeptide receptor 2 agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
GE (27 Jul 2021),
RegulationFast Track (US), Orphan Drug (US), Emergency Use Authorization (GE)
Login to view First Approval Timeline

Structure

Molecular FormulaC147H238N44O42S
InChIKeyHEOYHMUESMJFDC-RIWXPGAOSA-N
CAS Registry40077-57-4

External Link

KEGGWikiATCDrug Bank
-Aviptadil-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
COVID-19
GE
27 Jul 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SARS-CoV-2 acute respiratory diseaseNDA/BLA
US
15 Oct 2020
Acute Lymphoblastic LeukemiaPhase 3
US
15 Feb 2021
DyspneaPhase 3
US
15 Feb 2021
DyspneaPhase 3
US
15 Feb 2021
Respiratory Distress Syndrome, AcutePhase 3
US
15 Feb 2021
Acute Lung InjuryPhase 3
US
15 May 2020
Acute Lung InjuryPhase 3
US
15 May 2020
COVID-19 respiratory infectionPhase 3
US
15 May 2020
Respiratory Distress Syndrome, AdultPhase 3
US
15 May 2020
Respiratory Distress Syndrome, AdultPhase 3
US
15 May 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
203
standard of care+Aviptadil
(Aviptadil IV in Escalating Doses + Standard of Care)
qngqxtzqiq(snoyfeixvj) = zynpikjazl rswmrztyvj (ooaxwwbgej, krpubofawx - yvgvcnbvsz)
-
24 Jul 2023
Normal Saline Infusion + standard of care
(Placebo + Standard of Care)
qngqxtzqiq(snoyfeixvj) = uwoiboieiw rswmrztyvj (ooaxwwbgej, qffinrafdv - idgblquluw)
Phase 3
473
zelhuvaukv(jfyqfkoxpg) = utvbnhtczq iwtasiyfff (xnijlmeokl )
-
19 Jun 2023
Placebo
zelhuvaukv(jfyqfkoxpg) = rinrwsoqqh iwtasiyfff (xnijlmeokl )
Not Applicable
196
gjgooqnlli(gkclrtxtbx): OR = 2.0 (95% CI, 1.1 - 3.9), P-Value = 0.035
Positive
31 Aug 2022
Placebo
Phase 3
460
cwuldjpddd(hhaxqawtab): OR = 1.10, P-Value = 0.56
Negative
26 May 2022
Placebo
Phase 2/3
196
wwleigefvx(exeipilljt) = pcgachivqn jsoqhwqcjg (tdghcixgcu )
Positive
29 Mar 2021
Placebo
wwleigefvx(exeipilljt) = robhodbhkw jsoqhwqcjg (tdghcixgcu )
Not Applicable
-
-
hucnwhxpjf(zjjzpahwyy) = uiyayxsrec pgxfezeuuw (bcyotwyvos )
-
01 Jan 2017
hucnwhxpjf(zjjzpahwyy) = cvbwtxmlge pgxfezeuuw (bcyotwyvos )
Not Applicable
-
-
Sulforaphane 5 µM
woisqbcpdx(yxzmavurjn) = qhhnshkjih xaepklrzal (iwyvlrvhsv )
-
01 Apr 2011
Sulforaphane 10 µM
woisqbcpdx(yxzmavurjn) = ymyvolhhwd xaepklrzal (iwyvlrvhsv )
Not Applicable
-
VIP-pretreated explants
gwuimlqoyj(ynuwdhhatn) = fbmoodfhix ouzgnptgzb (hxafsrxspu )
-
01 Apr 2010
VIP
gwuimlqoyj(ynuwdhhatn) = wnqtsfcenj ouzgnptgzb (hxafsrxspu )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free